Breaking News

Caprion Acquires Serametrix Corp.

Expands immunology biomarker offering and provides CAP and CLIA-certified services for supporting Phase I-IV trials

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Caprion Biosciences acquired Serametrix Corp., a specialized provider of immune monitoring services headquartered in Carlsbad, CA. Caprion plans to leverage Serametrix expertise in the analysis of myeloid-derived suppressor cells (MDSC), as well as its international operations in the US, UK, Australia and China to expand its global geographic footprint. The acquisition also expands Caprion’s immune monitoring and biomarker services to the biopharmaceutical industry.   “Joining forc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters